Also trades as: CEROW (OTC) · $vol 0M
CERO OTC
CERo Therapeutics Holdings, Inc.
1W: -4.5%
1M: -33.5%
3M: -0.1%
YTD: -84.3%
1Y: -99.8%
3Y: -100.0%
$0.01
+0.00 (+0.00%)
Weekly Expected Move ±18.0%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$6M
+0.0% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$6M
+0.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$5M
+0.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| — Operating Activities — | ||||
| Net Income | -$11M | -$12M | -$7M | -$8M |
| Depreciation & Amort. | $735K | $1M | $1M | $1M |
| Stock-Based Comp. | $288K | $381K | $97K | $97K |
| Change in Working Capital | -$365K | $2M | $540K | $2M |
| Other Non-Cash Items | $9M | $7M | -$255K | -$537K |
| Operating Cash Flow | -$697K | -$1M | -$6M | -$6M |
| — Investing Activities — | ||||
| Capital Expenditures | -$613K | -$694K | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | -$325K | -$14M | $0 |
| Investment Sales | $0 | $0 | $6M | $0 |
| Other Investing | -$178M | $182M | $9M | $0 |
| Investing Cash Flow | -$178M | $181M | -$8K | $0 |
| — Financing Activities — | ||||
| Net Debt Issuance | $0 | $650K | $564K | -$14K |
| Stock Repurchased | $0 | -$139M | -$33K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Financing | $0 | -$139M | $0 | -$13M |
| Financing Cash Flow | $180M | -$139M | $572K | $572K |
| Net Change in Cash | $1M | $41M | -$5M | -$5M |
| Cash End of Period | $1M | $42M | $2M | $2M |
| Free Cash Flow | -$1M | -$2M | -$6M | -$6M |